Nokia producer gearing up for comeback
Finland-based HMD Global, the maker of Nokia phones, says it is planning a comeback after its crushing fall from the top by pushing use of a "pure Android" operating system (OS).
Finland-based HMD Global, the maker of Nokia phones, says it is planning a comeback after its crushing fall from the top by pushing use of a "pure Android" operating system (OS).
The state-owned Small and Medium Enterprise Development Bank (SME D Bank) expects its second batch of bonds worth 5 billion baht to get a warm welcome from institutional investors after a successful launch of the first lot.
The 1 Central Limited, the loyalty platform under Central Group of Companies, is spending about 1 billion baht during 2019-20 to upgrade its loyalty platform and expand a strategic partnerships both domestically and internationally.
Brands should not underestimate the purchasing power of secondary cities in Thailand like Lampang and Sakon Nakhon and avoid focusing solely on marketing in Bangkok, according to a report by Mindshare Thailand.
Property developer Siamese Asset Co will develop condo projects with a hotel business licence in Bangkok and other tourist destinations to tap rising demand from investment buyers.
The Energy Ministry expects the solar power project for household rooftops to achieve its projection of 15,000 participants by year-end thanks to the popularity of the trend globally and declining investment costs in the sector.
Fund inflows worth about 10 billion baht a month are anticipated in Thailand's stock market in the second half because of greater clarity on a coalition government, says the Federation of Thai Capital Market Organizations (Fetco).
Leon Edwards would like to fight Rafael dos Anjos in the UFC 242 co-main event.
Читать дальше...
These homemade blueberry muffins are light, fluffy, and PACKED with blueberries! They're an all-time favorite, perfect for weekend brunches and grab-and-go breakfast.
Continue reading "Blueberry Muffins" »
by Lauren M. Oko, Abigail K. Kimball, Rachael E. Kaspar, Ashley N. Knox, Carrie B. Coleman, Rosemary Rochford, Tim Chang, Benjamin Alderete, Linda F. van Dyk, Eric T. Clambey
Читать дальше...
by Sibusiso Sifunda, Karl Peltzer, Violeta J. Rodriguez, Lissa N. Mandell, Tae Kyoung Lee, Shandir Ramlagan, Maria L. Alcaide, Stephen M. Weiss, Deborah L. Jones
Читать дальше...
by Kyle L. Miller, Susette Castañeda Rico, Carly R. Muletz-Wolz, Michael G. Campana, Nancy McInerney, Lauren Augustine, Celine Frere, Alan M. Peters, Robert C. Fleischer
Читать дальше...
by Kiersten A. Wise, Damon Smith, Anna Freije, Daren S. Mueller, Yuba Kandel, Tom Allen, Carl A. Bradley, Emmanuel Byamukama, Martin Chilvers, Travis Faske, Andrew Friskop, Clayton Hollier, Tamra A. Jackson-Ziems, Heather Kelly, Bob Kemerait, Paul Price III, Alison Robertson, Albert Tenuta
Читать дальше...
by Ching-Hsue Cheng, Hsien-Hsiu Chen
Owing to the emergence of the Internet and its rapid growth, people can use mobile devices on many social media platforms (blogs, Facebook forums, etc.), and the platforms provide well-known websites for people to express and share their daily activities and ideas on global issues. Many consumers utilize product review websites before making a purchase. Many well-known websites are searched for relevant product reviews and experiences of product use. We... Читать дальше...
by Marion Fermaut, Arnaud Fauconnier, Aurélie Brossard, Jimmy Razafimamonjy, Xavier Fritel, Annie Serfaty
Читать дальше...
by Han-Gil Jeong, Jae Sun Yoon, Juneyoung Lee, Hee-Joon Bae
Background and purposeThe ticlopidine/Ginkgo biloba ext. combination drug (Yuclid) is used as an antiplatelet agent for prevention of vascular events since its approval in 2008. The purpose of this study is to explore the safety of ticlopidine/Ginkgo biloba combination, mainly regarding the incidence of neutropenia, through a post-marketing surveillance study.
MethodsFrom March 2009 to October 2015, a total of 4839 subjects had been enrolled in this study. Читать дальше...
by Ke Su, Song Liu, Tao Wu, Yingchao Yin, Ruipeng Zhang, Shilun Li, Yingze Zhang
by Gustav Zar, J. Gustav Smith, Maya Landenhed Smith, Bodil Andersson, Johan Nilsson
Читать дальше...
by Mary D. Adu, Usman H. Malabu, Aduli E. O. Malau-Aduli, Bunmi S. Malau-Aduli
Читать дальше...
by Ali Hajjar, Mehmet A. Ergun, Oguzhan Alagoz, Murtuza Rampurwala
ObjectivesAdjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in early-stage node-negative, HER2-positive breast cancer. We investigated the cost-effectiveness of this regimen.
MethodsA Markov-based microsimulation model with six health states is used to simulate four adjuvant therapy options for women with early-stage node-negative... Читать дальше...
by Yoon-Seok Chung, Ju-Yeon Choi, Myoung-Su Yoo, Jae Hyun Seong, Byeong-Sun Choi, Chun Kang
Читать дальше...
by Victoria Brings Bartsch, Jesse K. Niehaus, Bonnie Taylor-Blake, Mark J. Zylka
Читать дальше...
by Patricia M. Herman, Anita H. Yuan, Matthew S. Cefalu, Karen Chu, Qing Zeng, Nell Marshall, Karl A. Lorenz, Stephanie L. Taylor
Читать дальше...
by Qinghui You, Na Fang, Lingling Liu, Wenjing Yang, Li Zhang, Yeqiao Wang
Читать дальше...
by Keong-Hwan Kim, Han-Soo Kim, Michael Seungcheol Kang, Soo-Sung Park
Читать дальше...